Turner Syndrome Drug Market size is poised to witness over 7.8% CAGR during the forecast period i.e., between 2025-2037.
According to the National Library of Medicine in 2017, about 1 in every 2500 new-born girls, around the globe, were diagnosed with turner syndrome, making it one of the primary causes of female-fatal-miscarriages and stillbirths. According to report of National Institute of Health (NIH) U.S., the 45% of patients are affected with classic karyotype and the remaining 55% are affected with mosaic karyotype, a karyotype with abnormally in X chromosomes or may include Y chromosomes or its fragments. Besides, the female population increased from 3.6 billion in 2014 to 3.68 billion in 2016, according to the World Bank. Moreover, an increment of FDA approval for the treatment of the diseases along with the growing biotechnology sector and increasing awareness of women's health is expected to propel the growth of the market.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
7.8% |
Base Year Market Size (2024) |
|
Forecast Year Market Size (2037) |
|
Regional Scope |
|
The turner syndrome drug market is segmented by syndrome type, drug type, therapy type and by end-user. Among these segments, the end-user segment is further segmented to hospitals, homecare, specialty clinics, surgical centers and others, out of which, the segment of hospital is anticipated to hold the leading share in the market on account of availability of turner syndrome drugs used for the patient’s treatment only at the hospital. Global turner syndrome market is a highly disintegrated market and the major players have used various tactics such as joint ventures, partnerships, acquisitions, new product launches, expansion, agreement, and others to increase their mark in this market.
Our in-depth analysis of the global market includes the following segments
By Type |
|
By Drug Type |
|
By Therapy Type |
|
By End User |
|
On the basis of regional analysis, the turner syndrome drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.
North America industry is estimated to hold largest revenue share by 2037, on account of adoption of new technologies, existence developed economies, rising of healthcare expenditure and massive patient population. Europe holds the second-largest share in the market on account of rising research and development in the healthcare sector, mammoth patient population and growing biotechnology sector.
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?